<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2393-6797</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Medicina Interna ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Urug. Med. Int.]]></abbrev-journal-title>
<issn>2393-6797</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Interna del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2393-67972022000100004</article-id>
<article-id pub-id-type="doi">10.26445/07.01.1</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Impacto socioeconómico de pacientes asistidos en la policlínica de EPOC del Hospital Pasteur en 2018]]></article-title>
<article-title xml:lang="en"><![CDATA[Socioeconomic impact of patients served at the COPD polyclinic of Hospital Pasteur in 2018]]></article-title>
<article-title xml:lang="pt"><![CDATA[Impacto socio-econômico dos pacientes atendidos na polínica de DPOC do Hospital Pasteur em 2018]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[de Betolaza]]></surname>
<given-names><![CDATA[Sofía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Spiess]]></surname>
<given-names><![CDATA[Cecilia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amaro]]></surname>
<given-names><![CDATA[Maximiliano]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Revello]]></surname>
<given-names><![CDATA[Analet]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[Giuliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tasende]]></surname>
<given-names><![CDATA[Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Verde]]></surname>
<given-names><![CDATA[Daniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[Selene]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Clínica Médica 2]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>7</volume>
<numero>1</numero>
<fpage>4</fpage>
<lpage>16</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2393-67972022000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2393-67972022000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2393-67972022000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La EPOC es una enfermedad respiratoria prevalente con un importante impacto socioeconómico a nivel mundial. Existe escasa bibliografía que cuantifique la repercusión económica de la EPOC en países latinoamericanos.  Objetivos:  Estimar el impacto socioeconómico de pacientes con diagnóstico espirométrico de EPOC asistidos en la Policlínica de EPOC del Hospital Pasteur de Montevideo entre el 1º de enero de 2018 y el 31 de diciembre de 2018, determinando los costos directos de su atención.  Metodología:  Estudio observacional, descriptivo y transversal. Se obtuvieron datos de características demográficas, severidad y costos directos derivados de la atención sanitaria revisando historias clínicas.  Resultados:  De los 84 pacientes vistos en 2018, 57 tuvieron confirmación espirométrica. Predominó el sexo masculino (64.9%). La edad promedio fue 67.3 ± 11.09 años. 78.8% tenía primaria completa como nivel educativo más avanzado. El tabaquismo estuvo presente en 98.2%. La comorbilidad más prevalente fue el alcoholismo (36.8%), seguido por la hipertensión arterial (35.1%) 45.6% se encontraba en la categoría GOLD B de severidad, seguida por GOLD D 43,8%. Se analizaron costos directos derivados de la atención sanitaria en 49 pacientes. El total fue USD 190.552,46, correspondiendo 15% a medicamentos (55% oxígenoterapia domiciliaria), 76% exacerbaciones (98% internaciones), 2% estudios paraclínicos y 7% salario médico. Se observó un incremento de costos a medida que aumentaba la categoría de severidad no estadísticamente significativa, probablemente debido al n pequeño.  Conclusiones: La EPOC tiene una importante repercusión socioeconómica, principalmente determinada por los costos de las exacerbaciones.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  COPD is a prevalent respiratory disease with an important socioeconomic impact worldwide. There is scarce bibliography regarding COPD´s economic impact in Latin American countries. Objectives. To estimate the socioeconomic impact of patients with a COPD spirometric diagnosis assisted at Hospital Pasteur´s COPD clinic in Montevideo between January 1st 2018 and December 31st 2018, determining the direct costs related to their attention.  Methodology:  Observational, descriptive and transversal study. Data concerning demographic characteristics, severity and direct costs derived from health care was obtained revising clinical records.  Results:  57 out of the 84 patients seen in 2018 had spirometric confirmation. Male sex prevailed (64.9%). The average age was 67.3 ± 11.09 years. In 78.8% de most advanced education level achieved was primary school. Smoking was present in 98.2%. The most prevalent comorbidity was alcohol abuse (36.8%), followed by arterial hypertension (35.1%). 45.6% belonged to the severity category GOLD B, followed by GOLD D (43.8%). Direct costs were analyzed in 49 patients. The total cost was USD 190.552,46; 15% corresponded to medication (55% home oxygen therapy), 76% exacerbations (98% hospital admissions), 2% diagnostic and follow up studies and 7% doctors´ salary. We observed a tendency to an increase in costs when increasing the severity category which was not statistically significant, probably due to the low n.  Conclusions:  COPD has an important socioeconomic impact, determined mostly by the cost of exacerbations.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  A DPOC é uma doença respiratória prevalente com significativo impacto socioeconômico em todo o mundo. Há pouca literatura que quantifique o impacto econômico da DPOC em países da América Latina. Metas. Estimar o impacto socioeconômico de pacientes com diagnóstico espirométrico de DPOC atendidos na Policlínica de DPOC do Hospital Pasteur em Montevidéu entre 1º de janeiro de 2018 e 31 de dezembro de 2018, determinando os custos diretos de seus cuidados.  Metodologia:  Estudo observacional, extenso e transversal. Dados sobre características demográficas, gravidade e custos diretos decorrentes da assistência à saúde foram obtidos por meio de revisão de prontuários.  Resultados:  Dos 84 pacientes atendidos em 2018, 57 tiveram confirmação espirométrica. O sexo masculino predominou (64,9%). A média de idade foi de 67,3 ± 11,09 anos. 78,8% tinham o ensino fundamental completo como nível educacional mais avançado. O tabagismo esteve presente em 98,2%. A comorbidade mais prevalente foi o alcoolismo (36,8%), seguido de hipertensão arterial (35,1%) 45,6% estava na categoria GOLD B de gravidade, seguida de GOLD D 43,8%. Custos diretos derivados de cuidados de saúde em 49 pacientes foram analisados. O total foi de US$ 190.552,46, 15% correspondendo a medicamentos (55% oxigenoterapia domiciliar), 76% exacerbações (98% internações), 2% estudos paraclínicos e 7% salário médico. Observou-se aumento nos custos à medida que a categoria de gravidade aumentou, não estatisticamente significativo, provavelmente devido ao pequeno n.  Conclusões:  A DPOC tem um impacto socioeconômico significativo, determinado principalmente pelos custos das exacerbações.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[EPOC]]></kwd>
<kwd lng="es"><![CDATA[severidad]]></kwd>
<kwd lng="es"><![CDATA[costos directos]]></kwd>
<kwd lng="en"><![CDATA[COPD]]></kwd>
<kwd lng="en"><![CDATA[severity]]></kwd>
<kwd lng="en"><![CDATA[direct costs]]></kwd>
<kwd lng="pt"><![CDATA[DPOC]]></kwd>
<kwd lng="pt"><![CDATA[gravidade]]></kwd>
<kwd lng="pt"><![CDATA[custos diretos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Global Initiative for Chronic Obstructive Lung Disease</collab>
<source><![CDATA[Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease]]></source>
<year>2019</year>
<volume>155</volume>
<numero>96</numero>
<issue>96</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muiño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Menezes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de la enfermedad pulmonar obstructiva crónica y sus principales factores de riesgo: proyecto PLATINO en Montevideo]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2005</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>37-48</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Hermosa]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Sala Walther]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EPOC en individuos no fumadores]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2010</year>
<volume>46</volume>
<numero>Suppl 4</numero>
<issue>Suppl 4</issue>
<page-range>16-21</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soler-Cataluña]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Calle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Almagro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Quintano]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC) - Guía Española de la EPOC (GesEPOC)]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2017</year>
<volume>53</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>324-35</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hurst]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Vestbo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Anzueto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Locantore]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Müllerova]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Tal-Singer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Susceptibility to exacerbation in chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2010</year>
<volume>363</volume>
<page-range>1128-38</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wedzicha]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Seemungal]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COPD exacerbations defining their cause and prevention]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2007</year>
<volume>370</volume>
<page-range>786-96</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seemungal]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Bestall]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Jeffries]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wedzicha]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>1998</year>
<volume>157</volume>
<page-range>1418-22</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soler-Cataluna]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez-Garcia]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Roman Sanchez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ochando]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2005</year>
<volume>60</volume>
<page-range>925-31</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Eerd]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Smoking cessation for people with chronic obstructive pulmonary disease]]></article-title>
<collab>van der Meer RM.van Schayck OC.Kotz D</collab>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2016</year>
<volume>2016</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>CD010744</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>OBS Business School</collab>
<source><![CDATA[]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Universitat de Barcelona]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eisner]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Anthonisen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Coultas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kuenzli]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Perez-Padilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Postma]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An official American Thoracic Society public policy statement Novel risk factors and the global burden of chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2010</year>
<volume>182</volume>
<page-range>693-718</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández-Plata]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Métodos para estimación de costos en salud de la EPOC: resultados basales]]></article-title>
<source><![CDATA[Neumol Cir Tórax]]></source>
<year>2016</year>
<volume>75</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-11</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koul]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Nowshehr]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[UH]]></given-names>
</name>
<name>
<surname><![CDATA[Jan]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[SU]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India]]></article-title>
<source><![CDATA[Annals of Global Health]]></source>
<year>2019</year>
<volume>85</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deniz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[&#350;engül]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aydemir]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Çeldir Emre]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Özhan]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical factors and comorbidities affecting the cost of hospital-treated COPD]]></article-title>
<source><![CDATA[Int J Chron Obstruct Pulmon Dis]]></source>
<year>2016</year>
<volume>11</volume>
<page-range>3023-30</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Betolaza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Spiess]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Perera]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Algorta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio descriptivo de una población de pacientes EPOC asistidos en el Hospital Pasteur: severidad e impacto en la vida diaria]]></article-title>
<source><![CDATA[Rev Urug Med Int]]></source>
<year>2018</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>13-21</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ancochea]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio EPISCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2009</year>
<volume>45</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abascal]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Esteves]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Goja]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sica]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impacto de las políticas de control de tabaco en el Uruguay 2006-2009.: Programa Nacional para Control del Tabaco]]></article-title>
<source><![CDATA[Arch Med Int]]></source>
<year>2013</year>
<volume>35</volume>
<numero>Suppl 4</numero>
<issue>Suppl 4</issue>
<page-range>1-16</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rhee]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Yoo]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of Environmental Exposures on Patients with Chronic Obstructive Pulmonary Disease in Korea]]></article-title>
<source><![CDATA[Tuberc Respir Dis (Seoul)]]></source>
<year>2014</year>
<volume>76</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>226-32</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frantz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wollmer]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dencker]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Engström]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Nihlén]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Associations between lung function and alcohol consumption--assessed by both a questionnaire and a blood marker]]></article-title>
<source><![CDATA[Respir Med]]></source>
<year>2014</year>
<volume>108</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>114-21</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Figueira Gonçalves]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Dorta Sánchez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Pérez]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Viña Manrique]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Pérez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán Saenz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbilidad cardiovascular en pacientes con enfermedad pulmonar obstructiva crónica en Canarias (estudio CCECAN)]]></article-title>
<source><![CDATA[Clin Investig Arterioscler]]></source>
<year>2017</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>149-56</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Almagro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Diez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Boixeda]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso Ortiz]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Murio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD the EPOC en Servicios de medicina interna (ESMI) study]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2012</year>
<volume>142</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1126-33</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández-Plata]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Briseño]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[García-Sancho Figueroa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cano-Jiménez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Venegas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sansores-Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Métodos para la estimación de costos en salud de la EPOC resultados basales]]></article-title>
<source><![CDATA[Neumol cir torax]]></source>
<year>2016</year>
<volume>75</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-11</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
